Cargando…
Drosophila melanogaster: a first step and a stepping-stone to anti-infectives
Following an expansion in the antibiotic drug discovery in the previous century, we now face a bottleneck in the production of new anti-infective drugs. Traditionally, chemical libraries are screened either using in vitro culture systems or in silico to identify and chemically modify small molecules...
Autores principales: | Tzelepis, Ilias, Kapsetaki, Stefania-Elisavet, Panayidou, Stavria, Apidianakis, Yiorgos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185596/ https://www.ncbi.nlm.nih.gov/pubmed/23992884 http://dx.doi.org/10.1016/j.coph.2013.08.003 |
Ejemplares similares
-
Regenerative Inflammation: Lessons from Drosophila Intestinal Epithelium in Health and Disease
por: Panayidou, Stavria, et al.
Publicado: (2013) -
Metabolic output defines Escherichia coli as a health-promoting microbe against intestinal Pseudomonas aeruginosa
por: Christofi, Theodoulakis, et al.
Publicado: (2019) -
Drosophila melanogaster as a model for human intestinal infection and pathology
por: Apidianakis, Yiorgos, et al.
Publicado: (2011) -
Pseudomonas aeruginosa core metabolism exerts a widespread growth-independent control on virulence
por: Panayidou, Stavria, et al.
Publicado: (2020) -
Drosophila immune priming against
Pseudomonas aeruginosa is short-lasting and depends on cellular and humoral immunity
por: Christofi, Theodoulakis, et al.
Publicado: (2013)